The Swedish Competition Authority has recently published a report on the effects of the reregulation of the Swedish market for over the counter (OTC) pharmaceuticals. The report is partly based on a price comparison study by Copenhagen Economics, commissioned by the SCA, which concludes that customers purchasing their OTC on online pharmacies or in non-pharmacies seem to benefit from lower prices. However, there does not seem to be any effect on the prices in pharmacies, which are roughly 15% more expensive.

At the same time, online pharmacies (there is currently only one in Sweden) are the least expensive platform, and while a small market player, the competitive pressure they exert might contribute to increased service quality as tradi-tional pharmacies try to maintain their market share.

Learn more about the study

Learn more about the study on the Swedish Competition Authority’s website (Swedish)

For further information, please contact Karl Lundvall